Publication | Open Access

Phosphodiesterase inhibitors. Part 3: Design, synthesis and structure–activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity

Molecular PharmacologyMedicinal ChemistryPharmaceutical ChemistryBiochemistryMedicineNatural SciencesPhosphodiesterase InhibitorsPharmacological AgentStructure–activity RelationshipsPharmacologyDual Pde3/4-inhibitoryDrug Discovery